Complaints Outcomes

Search

Search Results

Search Again
Pharmacist Registrant 44 (Jul 7, 2020)

The Inquiry Committee, pursuant to section 32.3(3)(b)(ii) of the Health Professions Act, has reached an Agreement with the pharmacist registrant to voluntarily suspend their registration as a pharmacist effective July 7, 2020. The Agreement remains in effect until further notice. The Inquiry Committee considers the Agreement necessary to protect the public. The pharmacist registrant’s name has been withheld pursuant to section 39.3(4)(a) of the Health Professions Act.

Pharmacist Registrant 43 (Jun 16, 2020)

The Inquiry Committee has reinstated pharmacist registrant’s registration, which had previously been suspended for an indefinite period on April 8, 2020. The pharmacist registrant’s name has been withheld pursuant to section 39.3(4) of the Health Professions Act. 


April 8, 2020
(June 12, 2020 - Registration Reinstated)

The Inquiry Committee, pursuant to s. 32.3(3)(b)(ii) of the Health Professions Act, has reached an Agreement with the pharmacist registrant to voluntarily suspend the registration as a pharmacist effective April 8, 2020. The Agreement remains in effect until further notice. The Inquiry Committee considers the Agreement necessary to protect the public. The pharmacist registrant's name has been withheld pursuant to section 39.3(4)(a) of the Health Professions Act.

Sam, William Byron (Jun 15, 2020)
  1. Nature of Action: ​The Inquiry Committee of the College of Pharmacists of British Columbia (“CPBC”) conducted investigations into the practice of William Byron Sam (the “Registrant”), pursuant to section 33(4) of the Health Professions Act, R.S.B.C. 1996, c. 183 (“HPA”).

    The Inquiry Committee and the Registrant have agreed to resolve all matters arising from the investigations by way of a Consent Agreement under section 36(1) of the HPA.

  2. Effective date: June 15, 2020

  3. Name of registrant: William Byron Sam

  4. Location of Practice: Vancouver, BC

  5. Admissions and Acknowledgements:

    The Registrant has admitted and/or acknowledged the following: 

    1. The Registrant failed to respond in to correspondence from the College, including requests for information from College staff.

    2. The Registrant continued to engage in the practice of pharmacy at a time when his registration was cancelled contrary to s. 3 of the Pharmacists Regulation.

    3. The Registrant operated or permitted the operation of a pharmacy when not authorized under bylaw or by a pharmacy licence contrary to section 7(1) and (3) of the Pharmacy Operations and Drug Scheduling Act (“PODSA”).

    4. The Registrant sold and dispensed drugs to patients without having the correct information for the pharmacy on the label, contrary to section 9 of PODSA and section 9 of the Community Pharmacy Standards of Practice which are Part 1 of Schedule F to the HPA Bylaws. 

  6. Disposition:

    The Registrant entered into a Consent Agreement with the Inquiry Committee wherein the Registrant consented to the following terms (in part):

    1. cancellation of his registration,

    2. no right to apply for reinstatement for 3 years, and
       
    3. before submitting an application for reinstatement after 3 years, he must

      • pay a fine of $25,000, and
      • at his own expense, successfully complete all of
        • the College’s Jurisprudence Examination,
        • the Canadian Pharmacy Practice Program (CP3), and
        • the Pharmacy Examining Board of Canada, Pharmacist Qualifying Examination – Part II (OSCE);

       

  7. Rationale:

    There were previous issues with the Registrant regarding unresponsiveness to and disregard for the College and its regulatory requirements and its communications with him.

    The Registrant knowingly engaged in the practice of pharmacy at a time when he was not registered to do so.  He also knowingly operating an unlicensed pharmacy, contrary to the directions of the College.  Serious public risk factors were present within the pharmacy.

    The Inquiry Committee considered the terms of the Consent Agreement necessary to protect the public, as well as send a clear message of deterrence to the profession.


June 6, 2019
(June 15, 2020 - Registration Cancelled)

Pursuant to section 35(1)(b) of the Health Professions Act, the Inquiry Committee has ordered a suspension of the registration of registrant William Byron Sam pending completion of an investigation, effective June 6, 2019. The Registrant will not be able to practice pharmacy in the province of British Columbia while his registration is suspended. The Inquiry Committee considered the suspension necessary to protect the public.

The Inquiry Committee was satisfied on the information before it that there is a real risk to the public should this interim order not be put in place. The Registrant was knowingly operating an unlicensed pharmacy, contrary to the directions of the College. Serious public risk indicators were present within the pharmacy. The Registrant continued to display an inexplicable pattern of responsiveness to and disregard for the College and its regulatory requirements and its communications with him.

Note: Suspensions ordered by the Inquiry Committee under section 35(1)(b) of the Health Professions Act are made to protect the public during an investigation or pending a hearing of the Discipline Committee. Orders made under this section relate to matters which are and remain unproven unless admitted by a registrant or determined by the Discipline Committee.

Sharma, Shiv Kumar (Apr 15, 2020)
  1. Nature of Action: ​The Inquiry Committee of the College of Pharmacist of British Columbia (the “College”) conducted an investigation into the practice of Shiv Kumar Sharma (the “Registrant”), pursuant to section 33(1) of the Health Professions Act, R.S.B.C. 1996, c. 183. The Inquiry Committee and the Registrant have agreed to resolve all matters arising from the investigation by way of a Consent Agreement under section 36(1) of the Health Professions Act.

  2. Effective date: April 15, 2020

  3. Name of registrant: Shiv Kumar Sharma

  4. Location of Practice: Surrey, BC

  5. Admissions and Acknowledgements: The Registrant has admitted and/or acknowledged the following: 

    1. While he was director and pharmacy manager, pharmacy staff (including himself) altered PharmaNet entries for a patient creating an inaccurate patient record. Additionally, pharmacy staff (including himself) backdated the patient's prescriptions, meaning that the dispensing records for those prescriptions were created on dates later than the dates on which the drugs in question were actually dispensed, contrary to section 35(1) of the Bylaws to the Pharmacy Operations and Drug Scheduling Act; and

    2. The Registrant did not provide truthful or accurate information to the Investigator during the investigation into the matter, contrary to section 19 of the Bylaws to the Pharmacy Operations and Drug Scheduling Act

  6. Disposition:

    The Registrant entered into a Consent Agreement with the Inquiry Committee of CPBC, wherein the Registrant consented to the following terms (in part):

    1. To not be a pharmacy manager for a period of twenty-eight (28) days from April 17, 2020 to May 14, 2020;

    2. To not be a preceptor or supervisor of pharmacy students and/or international pharmacy graduates for a period of one year from April 15, 2020 to April 14, 2021;
       
    3. To pay a $1000.00 fine;

    4. To successfully pass the CPBC's Jurisprudence Exam; and

    5. To successfully complete and pass an ethics course designed specifically for health care professionals pass an ethics course for healthcare professionals;​

  7. Rationale:

    The Inquiry Committee considered that in this case, in addition to the serious misconduct, the Registrant placed his patient at significant risk of harm when he altered the patient’s PharmaNet record. His actions were a serious contravention of the standards in the Code of Ethics, and compromised the public’s trust in the pharmacy profession as a whole.

    The Inquiry Committee considered the totality of the Registrant’s conduct to be serious, and that he required remediation and a deterrence in order to come into compliance. The Inquiry Committee considered the terms of the Consent Agreement necessary to protect the public, as well as send a clear message of deterrence to the profession. 

Deol, Harpreet Singh (Feb 5, 2020)
  1. Nature of Action: ​The Inquiry Committee of the College of Pharmacist of British Columbia (the “College”) conducted an investigation into the practice of Harpreet Deol (the “Registrant”), pursuant to section 33(4) of the Health Professions Act, R.S.B.C. 1996, c. 183. The Inquiry Committee and the Registrant have agreed to resolve all matters arising from the investigation by way of a Consent Agreement under section 36(1) of the Health Professions Act.

  2. Effective date: February 5, 2020

  3. Name of registrant: Harpreet Singh Deol​

  4. Location of Practice: Abbotsford, BC

  5. Admissions and Acknowledgements:

    Between February 2018 and August 2019, the Registrant took unauthorized medications for his own personal use from the pharmacy for which he was director and pharmacy manager. The medications taken included, but were not limited to, 11,000 tablets and 116,000 millilitres of narcotic drug substances and 200 tablets and 7 vials of controlled drug substances, both of which require an authorized prescription.

    The Registrant did not process or bill these medications on PharmaNet and these medications were reportedly not provided to any other persons. All narcotic and controlled drug inventory was ordered and managed under the Registrant’s credentials and may have contributed to these losses going undetected.

    A College inspection conducted on August 7th, 2019 identified additional deficiencies in the Registrant’s management of the pharmacy and the pharmacy’s overall practice which included, but were not limited to, inaccurate dispensing of Methadone, inadequate/incomplete documentation, a lack of policies and procedures, inadequate record keeping and management of narcotic inventory, and inadequate pharmacy security

  6. Disposition:

    The Registrant entered into a Consent Agreement with the College’s Inquiry Committee, wherein the Registrant consented to terms that include (but are not limited to) the following:

    1. To suspend his registration as a pharmacist for a total of 90 days, ending September 9, 2020;

    2. To not be pharmacy manager, director, or officer of a pharmacy for a period of three years from September 10, 2020 to September 9, 2023;
       
    3. To not be a preceptor or supervisor of pharmacy students or international pharmacy graduates for a period of three years from September 10, 2020 to September 9, 2023;

    4. In relation to narcotic and controlled drugs, to not place and receive orders, destroy expired inventory, or have signing authority relating to the ordering of such substances for a period of three years from September 10, 2020 to September 9, 2023;

    5. To complete and successfully pass an ethics course for healthcare professionals;

    6. To complete and successfully pass training courses pertaining to the provision of Opioid Agonist Treatment (OAT) to patients and the management of a community pharmacy; and

    7. To pay a fine of $2,500.

  7. Rationale:

    The Inquiry Committee considered that in this case, in addition to the serious misconduct, the Registrant placed himself and his patients at significant risk of harm when he took unauthorized medications for personal use and continued to practice in the capacity of a pharmacist. His actions were a serious contravention of standards in the Code of Ethics, and compromised the public’s trust in the pharmacy profession as a whole.

    The Inquiry Committee therefore determined that the Registrant required serious remediation and deterrence regarding his conduct. After also considering significant mitigating factors, the Inquiry Committee considered the terms of the Consent Agreement appropriate to protect the public, as well as send a clear message of deterrence to the profession.

Bao, Leanne Hong Le (Jan 31, 2020)
  1. Nature of Action: ​The Inquiry Committee of the College of Pharmacists of British Columbia (“CPBC”) conducted an investigation into the practice of Leanne Hong Le Bao (the “Registrant”), pursuant to section 33(4) of the Health Professions Act, R.S.B.C. 1996, c. 183 (“HPA”).

    The Inquiry Committee and the Registrant have agreed to resolve all matters arising from the investigation by way of a Consent Agreement under section 36(1) of the HPA.

  2. Effective date: January 31, 2020

  3. Name of registrant: Leanne Hong Le Bao

  4. Location of Practice: Vancouver, BC

  5. Admissions and Acknowledgements:

    The Registrant has admitted and/or acknowledged the following (in part):

    1. The Registrant was in breach of her previous consented undertakings, which can be considered professional misconduct under section 26 of the HPA;
       
    2. The Registrant did not process methadone prescriptions on PharmaNet prior to dispensing on at least 25 occasions, contrary to section 21(1) now section 35(1) of the Pharmacy Operations and Drug Scheduling Act (“PODSA”), Bylaws;

    3. The Registrant did not ensure appropriate documentation and record keeping relating to Methadone Maintenance Treatment practices, contrary to principle 4.1.3 and 2.1.2 of Professional Practice Policy – 66;

    4. As pharmacy manager, the Registrant did not ensure that the pharmacy’s premise was suitable for operation, contrary to section 2(1)(b)(iv) of PODSA prior to April 1, 2018, section 11(2)(c)(d) now section 25(2)(c)(d) of the PODSA, Bylaws and section 8(a) of the Food and Drugs Act
       
  6. Disposition:

    The Registrant entered into a Consent Agreement with the Inquiry Committee of CPBC, wherein the Registrant consented to the following terms (in part): 

    1. To not be a pharmacy manager until:

      • She has completed Jurisprudence Exam;
      • She has completed “The BC Community Pharmacy Manager Training Program” offered by the British Columbia Pharmacy Association; and
      • She has met with the Deputy Registrar to reflect on her conduct and how she will improve her pharmacy practice going forward.
         
    2. To acknowledge a CPBC follow-up inspection may be conducted within a year; and
       
    3. To pay a $5,000.00 fine.​

  7. Rationale:

    The Registrant consented to undertakings in relation to a previous file. The undertakings in the previous file included the College conducting a follow-up inspection. Upon re-inspection, College investigators observed similar deficiencies, including narcotic counts and reconciliations were not completed, Methadone Maintenance Treatment documentation and record keeping were not appropriately completed, and the Pharmacy premise was not suitable for dispensing. Based on this, the Inquiry Committee determined the Registrant’s practice did not comply with the legislated practice standards and that the Registrant was in breach of her previous Consent Agreement, which can be considered as professional misconduct. The Inquiry Committee considered the Registrant’s conduct to be serious and that the Registrant required remediation and a deterrence in order for her practice to come into compliance.

    The Inquiry Committee considered the terms of the Consent Agreement necessary to protect the public, as well as send a clear message of deterrence to the profession. 

Wiebe, Shaun Ross (Dec 27, 2019)

Nature of Action: Pursuant to section 35(1)(b) of the Health Professions Act R.S.B.C. 1996, c. 183 (“HPA”), the Inquiry Committee of the College of Pharmacists of British Columbia (the “College”) has ordered a suspension of the registration of registrant Shaun Ross Wiebe pending completion of an investigation, unless he provides medical evidence from an addiction medicine specialist, satisfactory to the College, that he is fit to resume practice, or he successfully applies to the Inquiry Committee to cancel the suspension under section 35(4) of the HPA.

The registrant will not be able to practice pharmacy in the province of British Columbia while his registration is suspended.

Effective Date: December 27, 2019

Reasons: The Inquiry Committee was satisfied that there is a prima facie evidence that the registrant suffers from a substance addiction that renders him unfit to practice at this time. The Inquiry Committee was of the view that the registrant’s continued practice poses a risk to the public, and that this risk cannot be addressed at this time with conditions or limits. Therefore, nothing short of suspension at this time will adequately protect the public. 

Pharmacist Registrant 40 (Nov 24, 2019)

The Inquiry Committee has reinstated pharmacist registrant’s registration which had previously be suspended for an indefinite period on May 15, 2019. The pharmacist registrant’s name has been withheld pursuant to section 39.3(4) and (6) of the Health Professions Act.


May 15, 2019
(November 24, 2019 - Registration reinstated)

The Inquiry Committee, pursuant to section 32.2(4)(b)(ii) of the Health Professions Act, has reached an Agreement with the pharmacist registrant to voluntarily suspend the registration as a pharmacist effective May 15, 2019. The Agreement remains in effect until further notice. The Inquiry Committee considers the agreement necessary to protect the public. The pharmacist registrant’s name has been withheld pursuant to section 39.3(4)(a) of the Health Professions Act.

Pharmacy Technician Registrant 3 (Nov 22, 2019)

The Inquiry Committee has reinstated the pharmacy technician registrant’s registration which had previously been suspended for an indefinite period on September 1, 2018. Pursuant to section 32.2(4)(b)(i) of the Health Professions Act, the Inquiry Committee has reached an Agreement with the pharmacy technician registrant whereby the pharmacy technician registrant consented to terms including, but not limited to, the following:

  1. To comply with any and all recommendations and treatments prescribed or directed by the registrant’s physicians;
     
  2. To comply with every term of a routine medical monitoring program for a minimum of 36 consecutive months;
     
  3. To be restricted from handling, dispensing and packaging narcotics, controlled substances and sedatives, but not to be restricted from to be working in the same area and/or room where medications are stored, supplied and dispensed by other employees; 
     
  4. To be restricted from disposing or dealing with wastage or breakage of or otherwise handle any narcotics, controlled substances and sedatives;
     
  5. To be permanently restricted to working daytime hours with the latest time being 11:00pm on certain days;
     
  6. To ensure all managers and employers, with whom the registrant gains employment, are aware of the registrant’s limits and conditions on the registrant’s registration pursuant to the Agreement;
     
  7. To inform the College of the registrant’s place of employment as a pharmacy technician and report any changes to the location or management within 48 hours of such change; and
     
  8. To comply with the physician’s recommended schedule for a gradual return to work. 

September 1, 2018
(November 22, 2019 - Registration Reinstated)

The Inquiry Committee, pursuant to Section 36 of the Health Professions Act, has reached an agreement with pharmacy technician registrant to suspend her registration as a pharmacy technician for an indefinite period pending further decision of the Inquiry Committee. The Inquiry Committee considers the agreement necessary to protect the public. The registered pharmacy technician registrant's name has been withheld pursuant to 39.3(4) of the Health Professions Act.

Pharmacist Registrant 14 (Oct 18, 2019)

Pharmacist registrant 14 has satisfied the terms of an Agreement reached with the Inquiry Committee on January 23, 2013. Limits and conditions on the pharmacist registrant’s registration as a pharmacist have now been removed by the Inquiry Committee. The pharmacist registrant’s name has been withheld pursuant to 39.3(4) of the Health Professions Act


January 23, 2013
(October 18, 2019 – Limits and conditions removed) 

The Inquiry Committee has reinstated pharmacist registrant’s registration which was previously suspended for an indefinite period of time on December 10, 2012. Pursuant to Section 36 of the Health Professions Act, the Inquiry Committee has reached an agreement with pharmacist registrant to reinstate his registration to Full Pharmacist subject to certain limits and conditions, effective January 23, 2013. The Inquiry Committee considers the agreement necessary to protect the public. The pharmacist registrant's name has been withheld pursuant to 39.3(4) of the Health Professions Act.


December 24, 2012
(January 23, 2013 – Registration reinstated) 

The Inquiry Committee, pursuant to Section 36 of the Health Professions Act, has reached an agreement with pharmacist registrant to suspend his registration as a pharmacist for an indefinite period pending further disposition by the Inquiry Committee. The Inquiry Committee considers the agreement necessary to protect the public. The pharmacist registrant's name has been withheld pursuant to 39.3(4) of the Health Professions Act

Pages